GlaxoSmithKline pins hopes on return to normality as quarterly turnover slidesProactive Investors • 04/28/21
GlaxoSmithKline to drop quarterly results as Elliot presence signals it's time for changeProactive Investors • 04/27/21
Lloyds, GSK and Sainsbury's among mid-week reporters, Apple and Facebook earnings eyed alongside the FedProactive Investors • 04/27/21
FDA grants accelerated approval for GSK's JEMPERLI (dostarlimab-gxly) for women with recurrent or advanced dMMR endometrial cancerPRNewsWire • 04/22/21
Vectura confirms GlaxoSmithKline patent litigation is over, notes Hikma's launch of generic Advair DiskusProactive Investors • 04/21/21
GlaxoSmithKline biopharma spinoff to deliver solid sales growth contrary to market scepticism, says City brokerProactive Investors • 04/19/21
GlaxoSmithKline Surges On Report Activist Investor Takes 'Significant' StakeInvestors Business Daily • 04/15/21